Fund Holdings — Avoro Capital Advisors LLC

Total Portfolio Value
$10.15B
Total Bought
$1.33B
Total Sold
$1.17B
Net Transaction
+$164.44M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
UNITED THERAPEUTICS CORP(UTHR)2,606,0602,630,000+23,9401,269,8031,559,53715.36%+289,735
CYTOKINETICS INC(CYTK)03,333,333+3,333,3330219,7002.16%+219,700
APELLIS PHARMACEUTICALS INC
COM
12,222,22212,222,2220307,022491,7004.84%+184,678
TERNS PHARMACEUTICALS INC4,350,0005,695,000+1,345,000175,740300,2402.96%+124,500
DAMORA THERAPEUTICS INC(DMRA)03,783,000+3,783,000097,9800.97%+97,980
DEFINIUM THERAPEUTICS INC(DFTX)05,000,000+5,000,000094,5000.93%+94,500
XENON PHARMACEUTICALS INC(XENE)5,424,4445,777,777+353,333243,124335,9783.31%+92,854
CENTESSA PHARMACEUTICALS PLC14,555,55511,430,455-3,125,100364,034454,0184.47%+89,983
CELCUITY INC(CELC)3,111,1113,375,000+263,889310,302385,2233.79%+74,920
ASCENDIS PHARMA(ASND)5,111,1115,062,500-48,6111,089,8931,157,94611.41%+68,052
REVOLUTION MEDICINES INC(RVMD)2,170,0002,344,444+174,444172,841227,9972.25%+55,157
KYMERA THERAPEUTICS INC(KYMR)7,474,7477,474,7470581,610622,5726.13%+40,962
KRYSTAL BIOTECH INC(KRYS)2,888,8882,888,8880712,226746,2587.35%+34,031
AVALO THERAPEUTICS(AVTX)01,410,000+1,410,000021,0510.21%+21,051
ALKERMES PLC(ALKS)1,400,0001,200,000-200,00039,17242,4320.42%+3,260
WHITEHAWK THERAPEUTICS INC(WHWK)2,849,4022,849,40206,8969,8300.10%+2,935
GH RESEARCH PLC(GHRS)1,800,0001,800,000022,86025,3080.25%+2,448
SEPTERNA INC(SEPN)1,337,5001,337,500037,29032,1400.32%-5,149
INCYTE CORP(INCY)135,0000-135,00013,3340—-13,334
VIRIDIAN THERAPEUTICS INC(VRDN)1,500,0001,500,000046,68029,3400.29%-17,340
MANNKIND CORP(MNKD)4,444,4442,200,000-2,244,44425,2005,3900.05%-19,810
LEXEO THERAPEUTICS INC(LXEO)3,300,0001,875,000-1,425,00032,76910,7630.11%-22,006
TAYSHA GENE THERAPIES INC(TSHA)21,700,00021,700,0000119,35096,9990.96%-22,351
OCULAR THERAPEUTIX INC(OCUL)10,777,77712,315,000+1,537,223130,842104,3081.03%-26,534
ARROWHEAD PHARMACEUTICALS INC(ARWR)10,625,00010,699,999+74,999705,394670,8906.61%-34,504
APOGEE THERAPEUTICS INC(APGE)500,0000-500,00037,7400—-37,740
ORUKA THERAPEUTICS INC(ORKA)1,333,3400-1,333,34040,4140—-40,414
UNIQURE NV(QURE)6,150,0005,959,595-190,405147,17097,4390.96%-49,730
PTC THERAPEUTICS INC(PTCT)685,0000-685,00052,0330—-52,033
SOLENO THERAPEUTICS INC2,900,0002,300,000-600,000134,27077,0040.76%-57,266
VERA THERAPEUTICS INC(VERA)5,888,8885,888,8880298,213236,9102.33%-61,303
MIND MEDICINE (MINDMED) INC5,000,0000-5,000,00066,9500—-66,950
MADRIGAL PHARMACEUTICALS INC(MDGL)1,807,5001,818,181+10,6811,052,580951,7639.38%-100,816
ARGENX SE(ARGX)990,0001,000,000+10,000832,541730,2507.19%-102,290
STRUCTURE THERAPEUTICS INC6,555,5556,555,5550455,939315,9783.11%-139,961
SPDR SERIES TRUST - S&P BIOTECH
ST STR SP BIOT
2,100,0000-2,100,000256,0530—-256,053
AVIDITY BIOSCIENCES INC5,455,0000-5,455,000393,4690—-393,469
Page 1 of 1
Avoro Capital Advisors LLC — 13F Holdings — Q1 2026 | TickerTrail